Cite

HARVARD Citation

    Gajewski, T. et al. (n.d.). 239 Decr2 loss promotes resistance of tumor cells to immunotherapy by affecting CD8+ T cell-regulated tumor ferroptosis. Journal for immunotherapy of cancer. p. A142. [Online]. 
  
Back to record